<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02283398</url>
  </required_header>
  <id_info>
    <org_study_id>CARE-TAVI</org_study_id>
    <nct_id>NCT02283398</nct_id>
  </id_info>
  <brief_title>Cardioprotective Effect of RIPC in Patients Undergoing TAVI</brief_title>
  <acronym>CARE-TAVI</acronym>
  <official_title>The CARE-TAVI Study: Cardioprotective Effect of Remote Ischemic Preconditioning in Patients Undergoing Transcatheter Aortic Valve Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut für Pharmakologie und Präventive Medizin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut für Pharmakologie und Präventive Medizin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to investigate whether RIPC (remote ischemic preconditioning) is effective in the TAVI
      setting to reduce post-procedural myocardial damage and improve patient outcome. Accordingly,
      we aim to investigate whether RIPC can be introduced as an integral part of the TAVI
      procedure, in order to reduce post-procedural myocardial damage and potentially improve
      patient outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcatheter aortic valve implantation (TAVI) is associated to myocardial injury, defined as
      post-procedural cardiac troponin (cTn) elevation. Earlier experiences have shown that
      myocardial damage can be encountered in a percentage of patients that varies from 1.5% to
      17%, depending on the access route (transfemoral and transapical, respectively). The degree
      of rise in cTn after TAVI emerged as an independent predictor of mortality.

      Remote ischaemic preconditioning (RIPC) consists of brief episodes of ischaemia applied to
      remote organs or tissues and has shown to result in a significant reduction in postoperative
      troponin levels in cardiac and non-cardiac surgery patients. Lately, growing evidence
      suggests that post-procedural troponin decreases due to RIPC application protocols protocols
      and is associated with improved outcome.

      The patients will be divided into two Groups. In Group 1, RIPS will be induced with three
      cycles of Inflation of a blood-pressure cuff on the left arm to 200 mmHg for 5 min., followed
      by 5 min. of reperfusion while the cuff is deflated. In controls (Group 2), the cuff will be
      placed around the left arm without being inflated.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    administrative issues
  </why_stopped>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post-procedural myocardial injury, defined by the geometric mean (95% CI) of the area under the curve (AUC) for cTnT</measure>
    <time_frame>72 hours after intervention</time_frame>
    <description>Change in cardiac troponine T (cTnT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-procedural myocardial injury</measure>
    <time_frame>72 hours after intervention</time_frame>
    <description>defined by the geometric mean (95% CI) of the area under the curve (AUC) for CK-MB</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-procedural acute kidney injury</measure>
    <time_frame>72 hours after intervention</time_frame>
    <description>defined according to the VARC 2 criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-procedural brain injury</measure>
    <time_frame>72 hours after intervention</time_frame>
    <description>defined by the geometric mean (95% CI) of the area under the curve (AUC) for NSE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>composite of major adverse cardiac and cerebrovascular events</measure>
    <time_frame>discharge, at 30 days and at 1 year</time_frame>
    <description>including death, postoperative myocardial infarction and cerebrovascular accident or stroke</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Effectivity of RIPC in Outcomes of TAVI Procedure</condition>
  <arm_group>
    <arm_group_label>with RIPC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RIPC will be induced with three cycles of inflation of a blood-pressure cuff on the left arm to 200 mm Hg for 5 min, followed by 5 min of reperfusion while cuff deflated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without RIPC</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>the cuff will be placed around the left arm without being inflated</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>without RIPC</intervention_name>
    <description>the cuff will be placed around the left arm without being inflated</description>
    <arm_group_label>without RIPC</arm_group_label>
    <other_name>no remote ischemic preconditioning</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>RIPC</intervention_name>
    <description>RIPC will be induced with three cycles of inflation of a blood-pressure cuff on the left arm to 200 mm Hg for 5 min, followed by 5 min of reperfusion while cuff deflated</description>
    <arm_group_label>with RIPC</arm_group_label>
    <other_name>remote ischemic preconditioning</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for elective TAVI following Heart Team discussion

          -  Stable hemodynamic conditions without circulatory support or catecholamines

        Exclusion Criteria:

          -  Myocardial infarction at least 3 months before enrollment

          -  Stroke/TIA at least 3 months before enrollment

          -  Severe chronic kidney disease (defined as a baseline serum creatinine of &gt; 1.5 mg/dl
             or an estimated glomerular filtration rate (eGFR) of 60 ml/min/1.73 m2 )

          -  PCI at least 3 months before enrollment

          -  Abnormal (&gt;99th percentile of laboratory cut-off) baseline values of biomarkers of
             myocardial ischemia (i.e. TnT, CK-MB)

          -  Abnormal NSE values at baseline (local laboratory cut-off values)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Naber, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Elisabeth-Krankenhaus Essen, Klinik für Kardiologie und Angiologie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Dortmund, Medizinische Klinik Mitte - Kardiologie</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Klinikum Niederrhein, Kardiologie</name>
      <address>
        <city>Duisburg</city>
        <zip>47169</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2014</study_first_posted>
  <last_update_submitted>September 24, 2015</last_update_submitted>
  <last_update_submitted_qc>September 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

